Xisomab 3G3

Xisomab 3G3 · Aronora, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Xisomab 3G3, covering 2019-05-20 to 2024-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy [Phase 2]

See pricing